Drug profile · INN
isatuximab-irfc
SARCLISA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
isatuximab-irfc (SARCLISA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN isatuximab-irfc
Brand SARCLISA
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is isatuximab-irfc?
isatuximab-irfc (SARCLISA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for isatuximab-irfc?
SARCLISA is a marketed brand name for isatuximab-irfc. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of isatuximab-irfc?
isatuximab-irfc has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.